MetLife, Inc. $MET Shares Purchased by PensionDanmark Pensionsforsikringsaktieselskab

Posted by George Bondi on Aug 8th, 2026

PensionDanmark Pensionsforsikringsaktieselskab boosted its stake in MetLife, Inc. (NYSE:MET – Free Report) by 24.6% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 190,365 shares of the financial services provider’s stock after buying an additional 37,543 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in MetLife were worth $16,107,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the stock. Commonwealth Retirement Investments LLC boosted its holdings in shares of MetLife by 0.5% during the fourth quarter. Commonwealth Retirement Investments LLC now owns 26,953 shares of the financial services provider’s stock worth $2,128,000 after purchasing an additional 131 shares during the last quarter. CreativeOne Wealth LLC increased its stake in MetLife by 1.3% in the fourth quarter. CreativeOne Wealth LLC now owns 10,156 shares of the financial services provider’s stock valued at $802,000 after purchasing an additional 135 shares during the last quarter. Kathmere Capital Management LLC lifted its position in MetLife by 2.4% during the first quarter. Kathmere Capital Management LLC now owns 5,813 shares of the financial services provider’s stock worth $411,000 after buying an additional 136 shares during the period. Bridgewater Advisors Inc. boosted its stake in MetLife by 3.5% in the 4th quarter. Bridgewater Advisors Inc. now owns 4,113 shares of the financial services provider’s stock worth $315,000 after buying an additional 140 shares during the last quarter. Finally, Cornerstone Wealth Group LLC grew its holdings in MetLife by 5.1% in the 4th quarter. Cornerstone Wealth Group LLC now owns 2,931 shares of the financial services provider’s stock valued at $231,000 after buying an additional 141 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

Positive Sentiment: New $3 billion buyback: MetLife’s board authorized repurchases of up to 4.8% of outstanding shares through open-market purchases. The program signals management’s confidence in the company’s valuation and could support earnings per share over time. MetLife outlines new $3B buyback authorization
Positive Sentiment: Second-quarter earnings beat estimates: MetLife reported adjusted EPS of $2.43 versus consensus of $2.30, helped by higher investment income, favorable underwriting, and business-volume growth. Earnings also improved from $2.02 a year earlier. MetLife Tops Q2 Earnings Estimates
Positive Sentiment: Organic growth remains a key strength: Management highlighted underwriting performance and volume expansion, while maintaining its 2026 MetLife Investment Management outlook of $240 million to $280 million. Analysts described the results as supportive of the long-term buy case. MetLife Q2 Earnings Beat Reaffirms the Buy Case
Neutral Sentiment: Analysts remain cautiously optimistic: MetLife has outperformed the broader market over the past year, but valuation and the stock’s recent strength may leave less room for additional near-term gains. MetLife Stock Analyst Estimates and Ratings
Negative Sentiment: Spread headwinds and higher expenses remain risks: Management’s upbeat earnings commentary was tempered by pressure from investment spreads and elevated expenses, which could weigh on future profit growth despite favorable underwriting and investment income. MetLife Delivers Strong Earnings Amid Spread Headwinds

MetLife Stock Down 2.3%

MET opened at $97.61 on Friday. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $100.93. The firm has a 50 day moving average price of $90.10 and a 200 day moving average price of $80.82. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.20 and a current ratio of 0.20. The company has a market cap of $62.81 billion, a PE ratio of 18.70, a price-to-earnings-growth ratio of 0.76 and a beta of 0.78.

MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The firm had revenue of $13.52 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the previous year, the company posted $2.02 earnings per share. MetLife’s revenue was up 10.5% compared to the same quarter last year. Sell-side analysts expect that MetLife, Inc. will post 9.89 earnings per share for the current year.

MetLife announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be issued a dividend of $0.5925 per share. The ex-dividend date is Tuesday, August 4th. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. MetLife’s payout ratio is presently 45.93%.

Analysts Set New Price Targets

A number of research analysts have recently commented on MET shares. Keefe, Bruyette & Woods upped their price objective on shares of MetLife from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Monday, July 13th. Bank of America lowered their target price on shares of MetLife from $103.00 to $99.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Piper Sandler upped their price target on shares of MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Morgan Stanley increased their price target on shares of MetLife from $93.00 to $103.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Finally, Wells Fargo & Company lifted their price target on shares of MetLife from $95.00 to $101.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $100.71.

Read Our Latest Report on MetLife

About MetLife

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.